Flag of CanadaCanadian prices, in Canadian dollars

Generic tracker

Semaglutide generic tracker for Canada

What Health Canada has authorized, what is on the market, and which generic lots were recalled. Source: the Drug Product Database of Health Canada.

Last checked 2026-11-12

Key facts

The Drug Product Database of Health Canada shows 2 generic products with the status Marketed.

It shows 4 more generic products with an approval that are not on the market yet.

Health Canada posted 4 recalls of generic lots.

Generic semaglutide products

A product with the status Approved has an authorization. A product with the status Marketed is for sale in Canada.

ProductCompanyStatus in the databaseDIN
Sandoz SemaglutideSandoz Canada IncorporatedApproved since 2026-09-1602571501, 02571528
Semaglutide InjectionAspen Pharmacare Canada Inc.Approved since 2026-08-2502570912, 02570920
Aspen-SemaglutideAspen Pharmacare Canada Inc.Approved since 2026-07-1702569930, 02569949
SevmiaApotex IncApproved since 2026-06-2902569582
Apo-Semaglutide InjectionApotex IncMarketed since 2026-05-1402568012, 02568020
Semaglutide InjectionDr Reddy's Laboratories LtdMarketed since 2026-05-0602567806, 02567814

Brand semaglutide products

The products of the company that first made the medication.

ProductCompanyStatus in the databaseDIN
WegovyNovo Nordisk Canada IncMarketed since 2026-08-2702552698
OzempicNovo Nordisk Canada IncDormant since 2026-07-2402471477
PlosbrioNovo Nordisk Canada IncApproved since 2026-05-1102568233, 02568241
RybelsusNovo Nordisk Canada IncMarketed since 2026-03-1302551012, 02551020, 02551039
PlosbrioNovo Nordisk Canada IncApproved since 2025-12-2202564041, 02564068, 02564076, 02564084
PoviztraNovo Nordisk Canada IncApproved since 2025-12-2202564106, 02564114, 02564122, 02564130, 02564149, 02564157, 02564165, 02564173, 02564181, 02564203, 02564211
OzempicNovo Nordisk Canada IncApproved since 2025-11-0402562618, 02562626
WegovyNovo Nordisk Canada IncMarketed since 2024-04-2202528541
WegovyNovo Nordisk Canada IncMarketed since 2024-04-0202528517, 02528533
WegovyNovo Nordisk Canada IncMarketed since 2024-03-2802528509, 02528525
OzempicNovo Nordisk Canada IncMarketed since 2023-12-2202540258
OzempicNovo Nordisk Canada IncApproved since 2022-01-0402523930
WegovyNovo Nordisk Canada IncApproved since 2021-11-2302522551, 02522578, 02522586, 02522594, 02522608
RybelsusNovo Nordisk Canada IncMarketed since 2020-04-1902497581, 02497603, 02497611
OzempicNovo Nordisk Canada IncMarketed since 2018-02-2202471469

Recalls of generic lots

DateProductReason in the noticeNotice
2026-09-24Apo-Semaglutide Injection (Apotex Inc.)The affected lot may display a dose of 0.25 mg or 0.5 mg in the dose window and deliver one of these doses instead of the expected 1 mg dose.RA-82679
2026-08-27Apo-Semaglutide (Apotex Inc.)The affected lot may display a 2 mg dose in the dose window and deliver a 2 mg dose instead of the expected 0.25 mg or 0.5 mg dose.RA-82536
2026-08-26Semaglutide Injection (Dr. Reddy's Laboratories Canada Inc)An impurity is out of specification in all lots of the affected products.RA-82537
2026-08-11Semaglutide Injection (Dr. Reddy's Laboratories Canada Inc.)The affected lot contains a 4 mg pen but is labelled as a 2 mg pen.RA-82477

Where this comes from

Each row comes from the Drug Product Database of Health Canada, read on 2026-11-12. A row is one product name with one status. A product can have a DIN for each strength.

The recalls come from the recalls site of the Government of Canada. The date is the date of the last update of the notice.

Ask a pharmacist before you change a medication.